Literature DB >> 19836170

Is ecstasy a drug of dependence?

Louisa Degenhardt1, Raimondo Bruno, Libby Topp.   

Abstract

This paper examines the evidence for an MDMA or "ecstasy" dependence syndrome. Animal evidence suggests that MDMA may be a less potent reinforcer than other drugs, but that it does have dependence potential. This suggests that (a) ecstasy dependence might be less likely than dependence upon other drugs; and (b) factors related to the behavioural and psychological aspects of reward and dependence may make a relatively greater contribution for ecstasy than for other drugs, where physically centred (and better understood) features of dependence may be more salient. Human evidence supports this proposition. Some people report problems with their use, but the literature suggests that physical features play a more limited role than psychological ones. Tolerance is apparent, and withdrawal is self-reported, but it is unclear whether these reports distinguish sub-acute effects of ecstasy intoxication from symptoms reflective of neuroadaptive processes underlying a "true" withdrawal syndrome. Studies examining the structure of dependence upon ecstasy suggest it may be different from drugs such as alcohol, methamphetamine and opioids. Consistent with studies of hallucinogens, a two-factor structure has been identified with factors suggestive of "compulsive use" and "escalating use". Regardless of the nature of any dependence syndrome, however, there is evidence to suggest that a minority of ecstasy users become concerned about their use and seek treatment. Further controlled studies are required to investigate this phenomenon. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19836170     DOI: 10.1016/j.drugalcdep.2009.09.009

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  19 in total

Review 1.  The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.

Authors:  Philip Kamilar-Britt; Gillinder Bedi
Journal:  Neurosci Biobehav Rev       Date:  2015-09-25       Impact factor: 8.989

2.  Repeated MDMA administration increases MDMA-produced locomotor activity and facilitates the acquisition of MDMA self-administration: role of dopamine D2 receptor mechanisms.

Authors:  Ross van de Wetering; Susan Schenk
Journal:  Psychopharmacology (Berl)       Date:  2017-02-10       Impact factor: 4.530

3.  Tolerance to the locomotor-activating effects of 3,4-methylenedioxymethamphetamine (MDMA) predicts escalation of MDMA self-administration and cue-induced reinstatement of MDMA seeking in rats.

Authors:  Kevin T Ball; Mylissa Slane
Journal:  Behav Brain Res       Date:  2014-08-12       Impact factor: 3.332

4.  Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation.

Authors:  Renata Lisek; Wei Xu; Ekaterina Yuvasheva; Yi-Ting Chiu; Allen B Reitz; Lee-Yuan Liu-Chen; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2012-05-29       Impact factor: 4.492

5.  Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.

Authors:  Sean B Dolan; Michael J Forster; Michael B Gatch
Journal:  Drug Alcohol Depend       Date:  2017-08-24       Impact factor: 4.492

6.  Severity of club drug dependence and perceived need for treatment among a sample of adult club drug users in Shanghai, China.

Authors:  Yingying Ding; Na He; Steven Shoptaw; Meiyang Gao; Roger Detels
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-05-29       Impact factor: 4.328

7.  Effects of repeated exposure to MDMA on 5HT1a autoreceptor function: behavioral and neurochemical responses to 8-OHDPAT.

Authors:  Susan Schenk; Blaine Abraham; Dane Aronsen; Joyce Colussi-Mas; Jennifer Do
Journal:  Psychopharmacology (Berl)       Date:  2013-01-25       Impact factor: 4.530

8.  Developmental outcomes of 3,4-methylenedioxymethamphetamine (ecstasy)-exposed infants in the UK.

Authors:  Lynn T Singer; Derek G Moore; Meeyoung O Min; Julia Goodwin; John J D Turner; Sarah Fulton; Andrew C Parrott
Journal:  Hum Psychopharmacol       Date:  2015-07       Impact factor: 1.672

9.  Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  Behav Pharmacol       Date:  2016-09       Impact factor: 2.293

10.  Comparison of the effects of abstinence on MDMA and cocaine self-administration in rats.

Authors:  Quenten Highgate; Susan Schenk
Journal:  Psychopharmacology (Berl)       Date:  2018-09-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.